Biocon Limited (NSE:BIOCON)

Biocon Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	41,202	12,336	13,235	6,630	9,531
Short-Term Investments	4,473	10,248	19,585	20,501	16,470
Trading Asset Securities	-	3,156	4,443	2,518	6,237
Cash & Short-Term Investments	45,675	25,740	37,263	29,649	32,238
Cash Growth	77.45%	-30.92%	25.68%	-8.03%	73.70%
Accounts Receivable	54,879	62,306	35,732	20,582	15,097
Other Receivables	4,559	5,769	1,321	4,506	5,071
Receivables	59,438	68,075	37,053	25,759	20,168
Inventory	49,311	49,439	42,437	22,982	18,666
Prepaid Expenses	-	1,571	1,316	873	705
Other Current Assets	8,438	6,967	5,271	4,560	4,227
Total Current Assets	162,862	151,792	123,340	83,823	76,004
Property, Plant & Equipment	134,141	119,778	101,226	93,643	79,641
Long-Term Investments	6,797	6,843	8,673	3,702	8,821
Goodwill	167,857	163,724	161,362	264	264
Other Intangible Assets	102,719	102,867	105,259	12,887	11,736
Long-Term Deferred Tax Assets	2,577	3,173	3,010	2,933	3,077
Other Long-Term Assets	11,020	12,530	17,558	6,688	5,680
Total Assets	587,973	560,707	520,428	203,940	185,223
Accounts Payable	65,487	62,720	38,420	16,085	15,139
Accrued Expenses	-	2,906	4,840	1,741	1,700
Short-Term Debt	53,501	27,972	24,802	8,962	6,037
Current Portion of Long-Term Debt	-	-	-	95	8,028
Current Portion of Leases	674	547	390	211	84
Current Income Taxes Payable	1,731	2,769	2,250	1,618	1,524
Current Unearned Revenue	-	1,176	1,915	1,053	1,030
Other Current Liabilities	21,945	55,498	12,490	8,515	8,559
Total Current Liabilities	143,338	153,588	85,107	38,280	42,101
Long-Term Debt	124,054	129,324	152,905	39,985	29,616
Long-Term Leases	5,391	4,924	2,091	2,215	1,141
Long-Term Unearned Revenue	3,366	3,107	2,901	12,151	10,253
Long-Term Deferred Tax Liabilities	3,577	3,915	3,818	523	323
Other Long-Term Liabilities	31,122	12,000	47,684	15,169	15,651
Total Liabilities	310,848	307,959	295,540	109,240	100,147
Common Stock	6,003	6,003	6,003	6,003	6,000
Additional Paid-In Capital	-	2,285	1,735	1,192	619
Retained Earnings	-	177,906	162,476	69,890	63,975
Treasury Stock	-	-971	-971	-324	-1,343
Comprehensive Income & Other	210,437	12,614	9,426	7,564	7,018
Total Common Equity	216,440	197,837	178,669	84,325	76,269
Minority Interest	60,685	54,911	46,219	10,375	8,807
Shareholders' Equity	277,125	252,748	224,888	94,700	85,076
Total Liabilities & Equity	587,973	560,707	520,428	203,940	185,223
Total Debt	183,620	162,767	180,188	51,468	44,906
Net Cash (Debt)	-137,945	-137,027	-142,925	-21,819	-12,668
Net Cash Per Share	-115.17	-114.49	-119.51	-18.24	-10.59
Filing Date Shares Outstanding	1,196	1,197	1,194	1,193	1,189
Total Common Shares Outstanding	1,196	1,197	1,194	1,193	1,189
Working Capital	19,524	-1,796	38,233	45,543	33,903
Book Value Per Share	180.94	165.30	149.64	70.68	64.15
Tangible Book Value	-54,136	-68,754	-87,952	71,174	64,269
Tangible Book Value Per Share	-45.26	-57.45	-73.66	59.66	54.06
Land	-	3,373	2,918	2,805	2,695
Buildings	-	23,170	20,814	19,766	18,880
Machinery	-	103,389	97,262	76,553	69,865
Construction In Progress	-	39,852	25,875	34,203	22,535
Leasehold Improvements	-	2,686	2,518	116	81

Source: S&P Global Market Intelligence. Standard template. Financial Sources.